Syngene International
-
Syngene registers Rs 773 million PAT in Q1
Revenue from operations is up 41 per cent to Rs 5,945 million Syngene International announced its first-quarter results for FY22.…
Read More » -
Sanjeev Sukumaran joins Syngene International as CHRO
Sukumaran will be responsible for building on Syngene’s people-centric organisational development priorities including HR strategy development, driving organisational matrices Syngene…
Read More » -
Syngene International extends research collaboration with Bristol Myers Squibb until 2030
The extension envisions a 40 per cent increase in the number of scientists and the addition of a new 50,000…
Read More » -
Syngene in agreement with and Deerfield Discovery and Development
The collaboration will help to advance therapeutic discovery projects, from target validation through to pharmacological proof of concept and preclinical…
Read More » -
Syngene International joins global industry consortium
Syngene International has joined a global consortium of 19 organisations from the healthcare industry, led by Bristol Myers Squibb, to…
Read More »